Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
To test the safety and tolerability of ZD6474 in combination withVinorelbine (Navelbine) or
Gemcitabine (Gemzar) plus cisplatin as first line therapy in patients with locally advanced
or metastatic (Stage IIIB-IV) Non Small Cell Lung Cancer.